ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS
Clinical trials for ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Muscle-Weakening disease: multiple treatments tested in single trial
Disease control Recruiting nowThis study is testing several different drug combinations to find the safest and most effective treatments for myasthenia gravis, an autoimmune disease that causes muscle weakness. The trial will enroll about 70 adults who have been diagnosed with this condition and are currently…
Matched conditions: ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS
Sponsor: argenx • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug combo aims to boost muscle disease treatment
Disease control Recruiting nowThis study is testing whether adding a new drug called empasiprubart to an existing treatment (efgartigimod) can better control symptoms of myasthenia gravis. It will involve about 70 adults with a specific type of this muscle-weakening disease who have had only a partial improve…
Matched conditions: ACHR-AB SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC